http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010321773-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ec699c96c809fdf202410d55b5cd797 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2010-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e14df241e5fd619fa7a791d2ef80a5b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e5750f0fa6d143fdd5eb864eb116a7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e3c64bb0b276b5c208599a5425fd035 |
publicationDate | 2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2010321773-A1 |
titleOfInvention | Methods and compositions for treating hedgehog-associated cancers |
abstract | Provided herein are methods and compositions for treating or preventing a hedgehog-associated cancer (e.g., a hedgehog ligand-dependent cancer cell growth chosen from a neuroendocrine cancer, a sarcoma (e.g., a musculoskeletal sarcoma, such as chondrosarcoma and osteosarcoma)), a head and neck cancer, or a lung cancer by administering to a subject a hedgehog inhibitor, alone or combination with another anticancer agent (e.g., paclitaxel or a paclitaxel agent, a tyrosine kinase inhibitor (e.g., receptor tyrosine kinase (RTK) inhibitor) or an mTOR inhibitor). |
priorityDate | 2009-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1409.